APA (7th ed.) Citation

L, C., C, F., G, M., A, F., MT, B., AR, L., . . . G, A. (2023). Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: Cardiac safety analysis and final results of the COLTONE study. Clinical and experimental medicine, 23(8), 5113. https://doi.org/10.1007/s10238-023-01144-8

Chicago Style (17th ed.) Citation

L, Coltelli, et al. "Non-pegylated Liposomal Doxorubicin in Older Adjuvant Early Breast Cancer Patients: Cardiac Safety Analysis and Final Results of the COLTONE Study." Clinical and Experimental Medicine 23, no. 8 (2023): 5113. https://doi.org/10.1007/s10238-023-01144-8.

MLA (9th ed.) Citation

L, Coltelli, et al. "Non-pegylated Liposomal Doxorubicin in Older Adjuvant Early Breast Cancer Patients: Cardiac Safety Analysis and Final Results of the COLTONE Study." Clinical and Experimental Medicine, vol. 23, no. 8, 2023, p. 5113, https://doi.org/10.1007/s10238-023-01144-8.